An inventory of concerns behind blood safety policies in five Western countries

Transfusion

Volumn 55, Issue 12, 2015, Pages 2816-2825

  Kramer, Koen ^a,b   Verweij, Marcel F ^b   Zaaijer, Hans L ^a  

^a CENTRAL LABORATORY   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD SAFETY; CANADA; GERMANY; HEALTH CARE POLICY; HEPATITIS B VIRUS; MEDICAL DECISION MAKING; NETHERLANDS; NUCLEIC ACID ANALYSIS; Q FEVER; QUALITATIVE RESEARCH; RISK ASSESSMENT; UNITED KINGDOM; UNITED STATES; VARIANT CREUTZFELDT JAKOB DISEASE; WEST NILE VIRUS; DECISION MAKING; GREAT BRITAIN; HUMAN; MANAGEMENT;

BLOOD SAFETY; CANADA; DECISION MAKING; GERMANY; GREAT BRITAIN; HUMANS; NETHERLANDS; POLICY MAKING; QUALITATIVE RESEARCH; UNITED STATES;

EID: 84959558505     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13254     Document Type: Article

References (39)

1. Krever H., The royal commission of inquiry on the blood system in Canada. Final report: Commission of inquiry on the blood system in Canada. Ottawa: Canadian Government Publishing; 1997.
2. Leveton LB, Sox HC Jr, Stoto MA, editors. HIV and the blood supply: an analysis of crisis decisionmaking. Washington (DC): Institute of Medicine National Academy Press; 1995.
3. Bayer R, Feldman EA., Introduction: understand the blood feuds. In:, Feldman EA, Bayer R, editors. Blood feuds: AIDS, blood, and the politics of medical disaster. Oxford: Oxford University Press; 1999. p. 1-16.
4. Starr DP., Blood: an epic history of medicine and commerce. New York: Harper Collins; 2002.
5. Weinberg PD, Hounshell J, Sherman LA, et al., Legal, financial, and public health consequences of HIV contamination of blood and blood products in the 1980s and 1990s. Ann Intern Med 2002; 136: 312-9.
6. Dressler S., Blood "scandal" and AIDS in Germany. In:, Feldman EA, Bayer R, editors. Blood feuds: AIDS, blood, and the politics of medical disaster. Oxford: Oxford University Press; 1999. p. 191-212.
7. Epstein JS, Jaffe HW, Alter HJ, et al., Blood system changes since recognition of transfusion-associated AIDS: blood system changes since AIDS. Transfusion 2013; 53 (10 Pt 2): 2365-74.
8. Stoto MA., The precautionary principle and emerging biologic risks: lessons from human immunodeficiency virus in blood products. Semin Hematol 2006; 43: S10-2.
9. Glied S., The circulation of blood: AIDS, blood, and the economics of information. In:, Feldman EA, Bayer R, editors. Blood feuds: AIDS, blood, and the politics of medical disaster. Oxford: Oxford University Press; 1999. p. 323-47.
10. Marmor TR, Dillon PA, Scher S., Conclusion: the comparative politics of contaminated blood: from hesitancy to scandal. In:, Feldman EA, Bayer R, editors. Blood feuds: AIDS, blood, and the politics of medical disaster. Oxford: Oxford University Press; 1999. p. 349-66.
11. Alter HJ, Klein HG., The hazards of blood transfusion in historical perspective. Blood 2008; 112: 2617-26.
12. Evatt B., Infectious disease in the blood supply and the public health response. Semin Hematol 2006; 43: S4-9.
13. AuBuchon JP, Petz LD., Making decisions to improve transfusion safety. In:, AuBuchon JP, Petz LD, Fink A, editors. Policy alternatives in transfusion medicine. Bethesda: American Association of Blood Banks; 2001. p. 193-226.
14. Pereira A., Risk management. In:, Barbara JA, Regan FA, Contreras MC, editors. Transfusion microbiology. Cambridge: Cambridge University Press; 2008. p. 341-61.
15. Schippers EI., Brief van de Minister van Volksgezondheid, Welzijn en Sport [Internet]. The Hague: Tweede Kamer der Staten-Generaal; 2012 [cited 2015 Jan 16]. Available from: https://www.parlementairemonitor.nl/9353000/1/j4nvgs5kjg27kof-j9vvij5epmj1ey0/vj1afreph4ni/f=/kst2944718.pdf
16. Schippers EI., Ministerieel plan bloedvoorziening 2015-2017 [Internet]. The Hague: Tweede Kamer der Staten-Generaal; 2014 [cited 2015 Jan 16]. Available from: http://www.tweedekamer.nl/kamerstukken/detail?id=2014D32795&did=2014D32795
17. Zicht op zinnige en duurzame zorg [Internet]. Den Haag: Raad Voor de Volksgezondheid & Zorg; 2006 [cited 2015 Jan 16]. Available from: http://www.rvz.net/publicaties/bekijk/zinnige-en-duurzame-zorg
18. Steinbrook R., Saying no isn't NICE-the travails of Britain's National Institute for Health and Clinical Excellence. N Engl J Med 2008; 359: 1977-81.
19. Houweling H, Verweij M, Ruitenberg EJ., Criteria for inclusion of vaccinations in public programmes. Vaccine 2010; 28: 2924-31.
20. Van Hulst M, De Wolf JT, Staginnus U, et al., Pharmaco-economics of blood transfusion safety: review of the available evidence. Vox Sang 2002; 83: 146-55.
21. Borkent-Raven BA, Janssen MP, van der Poel CL, et al., Cost-effectiveness of additional blood screening tests in the Netherlands. Transfusion 2012; 52: 478-88.
22. Wilson K., A framework for applying the precautionary principle to transfusion safety. Transfus Med Rev 2011; 25: 177-83.
23. Vamvakas EC., Can policy decisions in transfusion medicine be evidence based? Decision making in transfusion medicine. Bethesda: American Association of Blood Banks; 2011. p. 1-29.
24. Risk-based decision-making framework for blood safety [Internet]. ••••••: Alliance of Blood Operators (ABO); 2015 Apr [cited 2015 June 10]. Available from: https://allianceofbloodoperators.org/media/115522/rbdm-framework-2-april-2015-v11-for-website.pdf
25. Menitove JE, Leach Bennett J, Tomasulo P, et al., How safe is safe enough, who decides and how? From a zero-risk paradigm to risk-based decision making: risk-based decision making. Transfusion 2014; 54 (3 Pt 2): 753-7.
26. Stein J, Besley J, Brook C, et al., Risk-based decision-making for blood safety: preliminary report of a consensus conference: risk-based decision-making. Vox Sang 2011; 101: 277-81.
27. Custer B, Janssen MP,; Alliance of Blood Operators Risk-Based Decision-Making (RBDM) Initiative. Health economics and outcomes methods in risk-based decision-making for blood safety. Transfusion 2015; 55: 2039-47.
28. Sugerman J, Devine DV., Ethical principles in transfusion medicine. In:, AuBuchon JP, Petz LD, Fink A, editors. Policy alternatives in transfusion medicine. Bethesda: American Association of Blood Banks; 2001. p. 19-41.
29. Bredehoeft SJ., Transfusion service directors: ethical dilemmas old and new. In:, Macpherson CR, Domen RE, Perlin T, editors. Ethical issues in transfusion medicine. Bethesda: American Association of Blood Banks; 2001. p. 71-87.
30. Chamber LA., New technologies and new dilemmas: biomedical ethics in transfusion medicine. In:, Macpherson CR, Domen RE, Perlin T, editors. Ethical issues in transfusion medicine. Bethesda: American Association of Blood Banks; 2001. p. 137-47.
31. Jackson BR, Busch MP, Stramer SL, et al., The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion 2003; 43: 721-9.
32. Grounded Theory Online. What is grounded theory? [Internet]. West Sussex: GTO; 2015 [cited 2015 Jan 16]. Available from: http://www.groundedtheoryonline.com/what-is-grounded-theory
33. Beauchamp TL, Childress JF., Principles of biomedical ethics. 5th ed. Oxford: Oxford University Press; 2001.
34. Molewijk B, Stiggelbout AM, Otten W, et al., Empirical data and moral theory. A plea for integrated empirical ethics. Med Health Care Philos 2004; 7: 55-69.
35. Hoffmaster B, Hooker C., How experience confronts ethics. Bioethics 2009; 23: 214-25.
36. Daniels N, Sabin JE., Limits to health care: fair procedures, democratic deliberation, and the legitimacy problem for insurers. Philos Public Aff 1997; 26: 303-50.
37. Daniels N, Sabin J,. The ethics of accountability and the reform of managed care organizations. Health Aff (Millwood) 1998; 17: 50-69.
38. Walzer M., Political action: the problem of dirty hands. Philos Public Aff 1973; 2: 160-80.
39. Hollis M., Dirty Hands. Br J Polit Sci 1982; 12: 385-98.